AC
EOLS icon

AXQ Capital’s Evolus EOLS Stock Holding History

AXQ Capital’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$196K Buy
+47,670
New +$231K 0.03% 757
2023
Q3 		– Sell
-12,039
Closed -$87.5K – 510
2023
Q2 		$87.5K Buy
+12,039
New +$104K 0.11% 245

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AXQ Capital's EOLS Position: Q1 2026 in Review

AXQ Capital opened a new position in Evolus (EOLS) in Q1 2026: 47,670 shares worth $196K. The stake represents 0.03% of the portfolio and ranks #757 among its holdings. This is a return to the name: AXQ Capital previously reported a position in EOLS as recently as Q2 2023.

AXQ Capital first reported a position in EOLS in Q2 2023 and has held it in 2 quarters since. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • AXQ Capital held 47,670 shares of Evolus worth $196K as of Q1 2026.
  • Evolus was a new AXQ Capital position in Q1 2026.
  • Evolus made up 0.03% of AXQ Capital's portfolio in Q1 2026, its #757 holding.
  • AXQ Capital first reported a position in Evolus in Q2 2023 and has held it in 2 quarters since.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.